• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗方案与口腔黏膜炎的发生率。一项综合综述。

Chemotherapy protocols and incidence of oral mucositis. An integrative review.

作者信息

Curra Marina, Soares Junior Luiz Alberto Valente, Martins Manoela Domingues, Santos Paulo Sérgio da Silva

机构信息

Universidade de Caxias do Sul, Caxias do Sul, RS, Brazil.

Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

Einstein (Sao Paulo). 2018;16(1):eRW4007. doi: 10.1590/s1679-45082018rw4007. Epub 2018 Apr 23.

DOI:10.1590/s1679-45082018rw4007
PMID:29694618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5968807/
Abstract

This review aimed to analyze the scientific production on severity of oral mucositis as an adverse effect of chemotherapy. To this end, we performed a search at PubMed databases combining the keywords "oral mucositis" and "chemotherapy protocol". To describe the investigation, the following variables were considered: journal, year/place, study design, sample, protocol used and incidence of oral mucositis. A total of 547 articles were retrieved, of which 26 were selected. Out of these 26, only 2 reported severity of oral mucositis; the others only reported the presence of the condition. Protocols for treating different types of carcinoma were evaluated in 16 (61.53%) studies, for hematological malignancies in 6 (23.07%), and for hematopoietic stem cell transplantation in 4 (15.4%). Protocols for hematopoietic stem cell transplantation entail a high risk for oral mucositis, just as chemotherapy with cytarabine and high-dose 5-fluorouracil, alkylating agents and platinumbased compounds. To provide the best prevention and treatment for oral mucositis, it is essential to know the chemotherapy protocols used and their effects on the oral cavity.

摘要

本综述旨在分析作为化疗不良反应的口腔黏膜炎严重程度的科研成果。为此,我们在PubMed数据库中进行了检索,将关键词“口腔黏膜炎”和“化疗方案”相结合。为描述该调查,考虑了以下变量:期刊、年份/地点、研究设计、样本、所用方案以及口腔黏膜炎的发生率。共检索到547篇文章,其中26篇被选中。在这26篇中,只有2篇报告了口腔黏膜炎的严重程度;其他文章仅报告了该病的存在情况。16项(61.53%)研究评估了治疗不同类型癌症的方案,6项(23.07%)研究评估了血液系统恶性肿瘤的方案,4项(15.4%)研究评估了造血干细胞移植的方案。造血干细胞移植方案导致口腔黏膜炎的风险很高,阿糖胞苷和高剂量5-氟尿嘧啶化疗、烷化剂和铂类化合物化疗也是如此。为了为口腔黏膜炎提供最佳的预防和治疗,了解所用的化疗方案及其对口腔的影响至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a9f/5968807/00620aefebc5/1679-4508-eins-16-01-eRW4007-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a9f/5968807/00620aefebc5/1679-4508-eins-16-01-eRW4007-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a9f/5968807/00620aefebc5/1679-4508-eins-16-01-eRW4007-gf01.jpg

相似文献

1
Chemotherapy protocols and incidence of oral mucositis. An integrative review.化疗方案与口腔黏膜炎的发生率。一项综合综述。
Einstein (Sao Paulo). 2018;16(1):eRW4007. doi: 10.1590/s1679-45082018rw4007. Epub 2018 Apr 23.
2
Prophylactic Effect of Polaprezinc, a Zinc-L-carnosine, Against Chemotherapy-induced Oral Mucositis in Pediatric Patients Undergoing Autologous Stem Cell Transplantation.锌-L-肌肽(聚普瑞锌)对接受自体干细胞移植的儿科患者化疗引起的口腔黏膜炎的预防作用。
Anticancer Res. 2018 Aug;38(8):4691-4697. doi: 10.21873/anticanres.12775.
3
Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.前瞻性口腔黏膜炎审计:接受大剂量美法仑或BEAM预处理化疗患者的口腔黏膜炎——欧洲血液与骨髓移植学会黏膜炎咨询小组
J Clin Oncol. 2008 Mar 20;26(9):1519-25. doi: 10.1200/JCO.2007.13.6028. Epub 2008 Feb 11.
4
Laser Therapy as a Preventive Approach for Oral Mucositis in Cancer Patients Undergoing Chemotherapy: The Potential Role of Superoxide Dismutase.激光治疗作为预防癌症患者化疗后口腔黏膜炎的方法:超氧化物歧化酶的潜在作用。
Asian Pac J Cancer Prev. 2021 Oct 1;22(10):3211-3217. doi: 10.31557/APJCP.2021.22.10.3211.
5
Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experience.帕利夫明用于高剂量化疗和干细胞移植环境下的口腔黏膜炎:皇家阿德莱德医院癌症中心的经验
Support Care Cancer. 2006 Jun;14(6):580-2. doi: 10.1007/s00520-006-0048-3. Epub 2006 May 3.
6
Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi-institutional randomized controlled trial.聚维酮碘溶液预防化疗后造血干细胞移植患者口腔黏膜炎的多中心随机对照研究。
Int J Cancer. 2021 Mar 15;148(6):1462-1469. doi: 10.1002/ijc.33316. Epub 2020 Oct 14.
7
Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.帕利夫明(凯纷)用于治疗需要造血干细胞支持的血液系统恶性肿瘤患者的口腔黏膜炎。
J Oncol Pharm Pract. 2005 Sep;11(3):121-5. doi: 10.1191/1078155205jp159oa.
8
[The state-of-the-art development in research on oral mucositis induced by chemotherapy].[化疗所致口腔黏膜炎的研究进展]
Zhonghua Kou Qiang Yi Xue Za Zhi. 2018 Aug 9;53(8):566-571. doi: 10.3760/cma.j.issn.1002-0098.2018.08.015.
9
Prophylaxis for mucositis induced by ambulatory chemotherapy: systematic review.门诊化疗所致黏膜炎的预防:系统评价
J Adv Nurs. 2016 Apr;72(4):735-46. doi: 10.1111/jan.12867. Epub 2015 Dec 2.
10
Preparation and clinical evaluation of a novel lozenge containing polaprezinc, a zinc-L-carnosine, for prevention of oral mucositis in patients with hematological cancer who received high-dose chemotherapy.含聚普瑞锌(一种锌-L-肌肽)的新型含片用于预防接受大剂量化疗的血液系统癌症患者口腔黏膜炎的制备及临床评价
Med Oncol. 2016 Aug;33(8):91. doi: 10.1007/s12032-016-0795-z. Epub 2016 Jul 14.

引用本文的文献

1
Predictive models for chemotherapy-induced oral mucositis: a systematic review.化疗引起的口腔黏膜炎的预测模型:一项系统综述
Front Oncol. 2025 Aug 20;15:1608505. doi: 10.3389/fonc.2025.1608505. eCollection 2025.
2
Micro and Nano Drug Delivery Systems for the Treatment of Oral Mucositis: A Review.用于治疗口腔黏膜炎的微纳米药物递送系统:综述
Pharmaceutics. 2025 Aug 7;17(8):1025. doi: 10.3390/pharmaceutics17081025.
3
Elevated Likelihood of Infectious Complications Related to Oral Mucositis After Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis of Outcomes and Risk Factors.

本文引用的文献

1
Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy.基于机制的黏膜炎管理:在不影响癌症治疗疗效的情况下治疗副作用的选择。
Onco Targets Ther. 2016 Apr 5;9:2007-16. doi: 10.2147/OTT.S96899. eCollection 2016.
2
The influence of dental care associated with laser therapy on oral mucositis during allogeneic hematopoietic cell transplant: retrospective study.异基因造血细胞移植期间激光治疗相关牙科护理对口腔黏膜炎的影响:回顾性研究
Einstein (Sao Paulo). 2011 Jun;9(2):201-6. doi: 10.1590/S1679-45082011AO1848.
3
Induction therapy with cetuximab plus docetaxel, cisplatin, and 5-fluorouracil (ETPF) in patients with resectable nonmetastatic stage III or IV squamous cell carcinoma of the oropharynx. A GERCOR phase II ECHO-07 study.
造血干细胞移植后与口腔黏膜炎相关的感染并发症可能性增加:结局与风险因素的系统评价和荟萃分析
Cancers (Basel). 2025 Aug 14;17(16):2657. doi: 10.3390/cancers17162657.
4
Multi-institutional, randomized, controlled trial to assess the efficacy and tolerability of a reusable, self-contained cryotherapy delivery device.多机构随机对照试验,以评估一种可重复使用、自成一体的冷冻治疗设备的疗效和耐受性。
Support Care Cancer. 2025 Jul 31;33(8):732. doi: 10.1007/s00520-025-09795-x.
5
Oral Management Improves Patient Outcomes in Hematopoietic Stem Cell Transplantation.口腔管理改善造血干细胞移植患者的预后。
Int Dent J. 2025 May 9;75(4):100822. doi: 10.1016/j.identj.2025.04.003.
6
Protective effect of adenosine triphosphate against cisplatin-induced necrotic and degenerative oral mucositis in rats.三磷酸腺苷对顺铂诱导的大鼠坏死性和退行性口腔黏膜炎的保护作用。
J Appl Oral Sci. 2025 Mar 24;33:e20250007. doi: 10.1590/1678-7757-2025-0007. eCollection 2025.
7
Oral frailty and its influencing factors in patients with cancer undergoing chemotherapy: a cross-sectional study.癌症化疗患者的口腔衰弱及其影响因素:一项横断面研究。
BMC Oral Health. 2025 Mar 24;25(1):426. doi: 10.1186/s12903-025-05789-7.
8
Photobiomodulation preconditioning for oral mucositis prevention and quality of life improvement in chemotherapy patients: a randomized clinical trial.光生物调节预处理对化疗患者口腔黏膜炎的预防及生活质量改善作用:一项随机临床试验
BMC Oral Health. 2025 Feb 5;25(1):190. doi: 10.1186/s12903-025-05579-1.
9
Incidence of oral manifestations in hematological malignancy patients undergoing chemotherapy: prospective cohort study.血液系统恶性肿瘤患者化疗期间口腔表现的发生率:前瞻性队列研究。
Med Oral Patol Oral Cir Bucal. 2025 Jan 1;30(1):e17-e23. doi: 10.4317/medoral.26652.
10
Evaluation of the Incidence and Stage of Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Study.造血干细胞移植患者口腔黏膜炎发病率及分期的评估:一项回顾性研究
Florence Nightingale J Nurs. 2024 Nov 6;32(3):261-268. doi: 10.5152/FNJN.2024.23049.
西妥昔单抗联合多西他赛、顺铂和5-氟尿嘧啶(ETPF)用于可切除的非转移性III期或IV期口咽鳞状细胞癌患者的诱导治疗。GERCOR II期ECHO-07研究。
Cancer Med. 2015 May;4(5):721-31. doi: 10.1002/cam4.408. Epub 2015 Feb 14.
4
Gastrointestinal adverse effects in advanced colorectal carcinoma patients treated with different schedules of FOLFOX.接受不同方案FOLFOX治疗的晚期结直肠癌患者的胃肠道不良反应
Asian Pac J Cancer Prev. 2014;15(19):8089-93. doi: 10.7314/apjcp.2014.15.19.8089.
5
Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx.顺铂、替加氟和亚叶酸钙同步放化疗用于晚期下咽和口咽鳞状细胞癌
Biomed J. 2014 May-Jun;37(3):133-40. doi: 10.4103/2319-4170.117893.
6
Adverse event management in patients with advanced cancer receiving oral everolimus: focus on breast cancer.晚期癌症患者接受口服依维莫司治疗的不良事件管理:重点关注乳腺癌。
Ann Oncol. 2014 Apr;25(4):763-773. doi: 10.1093/annonc/mdu021.
7
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.MASCC/ISOO 临床实践指南:癌症治疗相关黏膜炎的管理。
Cancer. 2014 May 15;120(10):1453-61. doi: 10.1002/cncr.28592. Epub 2014 Feb 25.
8
Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma.儿童和青少年鼻咽癌同步整合加量调强放射治疗的长期疗效和晚期毒性
Chin J Cancer. 2013 Oct;32(10):525-32. doi: 10.5732/cjc.013.10124. Epub 2013 Sep 10.
9
Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma.顺铂和5-氟尿嘧啶正弦波时辰调制与固定间歇诱导化疗后传统放疗治疗局部晚期鼻咽癌的随机研究
Chin J Cancer. 2013 Sep;32(9):502-11. doi: 10.5732/cjc.013.10004. Epub 2013 Jul 2.
10
Efficacy, safety, pharmacokinetics and biomarker findings in patients with HER2-positive advanced or metastatic breast cancer treated with lapatinib in combination with capecitabine: results from 51 Japanese patients treated in a clinical study.拉帕替尼联合卡培他滨治疗HER2阳性晚期或转移性乳腺癌患者的疗效、安全性、药代动力学及生物标志物研究结果:一项临床研究中51例日本患者的研究结果
Breast Cancer. 2015 Mar;22(2):192-200. doi: 10.1007/s12282-013-0475-1. Epub 2013 May 21.